MDL100907 hydrochloride (Water soluble)

(HB12412)
Technical documents: CoA Datasheet

Product overview

Name MDL100907 hydrochloride (Water soluble)
Alternative names Volinanserin hydrochloride
Description Potent and selective 5-HT2A receptor antagonist. Water soluble.
Write Your Own Review
You're reviewing:MDL100907 hydrochloride (Water soluble)
Rate this item:

Biological Data

Biological description

More convenient and easier to use water soluble version of MDL 100907, which is only soluble in DMSO and HCl. MDL 100907 is a potent and selective 5-HT2A receptor antagonist (Ki = 0.36 nM). Shows > 80-fold selectivity for 5-HT2A over other 5-HT receptor subtypes. Displays antipsychotic actions. Active in vivo.

Solubility & Handling

Storage instructions +4°C
Solubility overview soluble in water (100mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Chemical name (R)-(+)-α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperinemethanol hydrochloride
Molecular Weight 409.92
Chemical structure  Chemical Structure
Molecular Formula C22H28FNO3.HCl
SMILES [Cl-].[H][N+]1(CCC2=CC=C(F)C=C2)CCC(CC1)C(O)C1=CC=CC(OC)=C1OC
Source Synthetic
InChi InChI=1/C22H28FNO3.ClH/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16;/h3-9,17,21,25H,10-15H2,1-2H3;1H
Appearance white solid

References for MDL100907 hydrochloride (Water soluble)

References are publications that support the biological activity of the product
  • Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.

    Minabe Y et al (2001) Synapse (New York, N.Y.) 40 : 102-12
  • Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.

    Kehne JH et al (1996) The Journal of pharmacology and experimental therapeutics 277 : 968-81
  • Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

    Sorensen SM et al (1993) The Journal of pharmacology and experimental therapeutics 266 : 684-91

3 Item(s)